Revelation Biosciences, Inc.
REVB
$3.08
$0.082.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.73M | -2.24M | -8.39M | -2.68M | -2.20M |
| Total Depreciation and Amortization | 7.20K | 7.20K | 7.20K | 6.30K | 6.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 70.00K | 26.10K | 52.70K | -36.30K | -36.10K |
| Change in Net Operating Assets | -2.10M | -7.05M | 5.85M | -126.50K | 229.90K |
| Cash from Operations | -3.75M | -9.26M | -2.48M | -2.84M | -2.00M |
| Capital Expenditure | 17.70K | -17.70K | 0.00 | -19.20K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.70K | -17.70K | 0.00 | -19.20K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.69M | 3.74M | 0.00 | 5.42M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.69M | 3.74M | 0.00 | 5.42M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.00K | -5.53M | -2.48M | 2.56M | -2.00M |